|
1
|
Niknami Z, Eslamifar A, Emamirazavi A,
Ebrahimi A and Shirkoohi R: The association of vimentin and
fibronectin gene expression with epithelial-mesenchymal transition
and tumor malignancy in colorectal carcinoma. EXCLI J.
16:1009–1017. 2017.PubMed/NCBI
|
|
2
|
Xu RH, Shen L, Li J, Xu JM, Bi F, Ba Y,
Bai L, Shu YQ, Liu TS, Li YH, et al: Expert consensus on
maintenance treatment for metastatic colorectal cancer in China.
Chin J Cancer. 35:132016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin CM, Han K, Lee DH, Choi YJ, Kim N,
Park YS and Yoon H: Association among obesity, metabolic health,
and the risk for colorectal cancer in the general population in
Korea using the National Health Insurance Service-National Sample
Cohort. Dis Colon Rectum. 60:1192–1200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lopes-Ramos CM, Barros BP, Koyama FC,
Carpinetti PA, Pezuk J, Doimo NT, Habr-Gama A, Perez RO and
Parmigiani RB: E2F1 somatic mutation within miRNA target site
impairs gene regulation in colorectal cancer. PLoS One.
12:e01811532017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jayasekara H, English DR, Haydon A, Hodge
AM, Lynch BM, Rosty C, Williamson EJ, Clendenning M, Southey MC1,
Jenkins MA, et al: Associations of alcohol intake, smoking,
physical activity and obesity with survival following colorectal
cancer diagnosis by stage, anatomic site and tumor molecular
subtype. Int J Cancer. 142:238–250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Altobelli E, Latella G, Morroni M, Licini
C, Tossetta G, Mazzucchelli R, Profeta VF, Coletti G, Leocata P,
Castellucci M, et al: Low HtrA1 expression in patients with long
standing ulcerative colitis and colorectal cancer. Oncol Rep.
38:418–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nandra R, Parry M, Forsberg J and Grimer
R: Can a bayesian belief network be used to estimate 1-year
survival in patients with bone sarcomas? Clin Orthop Relat Res.
475:1681–1689. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yogarajah M and Tefferi A: Leukemic
transformation in myeloproliferative neoplasms: A literature review
on risk, characteristics, and outcome. Mayo Clin Proc.
92:1118–1128. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fujieda Y, Amengual O, Matsumoto M, Kuroki
K, Takahashi H, Kono M, Kurita T, Otomo K, Kato M, Oku K, et al:
Ribophorin II is involved in the tissue factor expression mediated
by phosphatidylserine-dependent antiprothrombin antibody on
monocytes. Rheumatology (Oxford). 55:1117–1126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ono M, Tsuda H, Kobayashi T, Takeshita F,
Takahashi RU, Tamura K, Akashi-Tanaka S, Moriya T, Yamasaki T,
Kinoshita T, et al: The expression and clinical significance of
ribophorin II (RPN2) in human breast cancer. Pathol Int.
65:301–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Honma K, Iwao-Koizumi K, Takeshita F,
Yamamoto Y, Yoshida T, Nishio K, Nagahara S, Kato K and Ochiya T:
RPN2 gene confers docetaxel resistance in breast cancer. Nat Med.
14:939–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tominaga N, Hagiwara K, Kosaka N, Honma K,
Nakagama H and Ochiya T: RPN2-mediated glycosylation of tetraspanin
CD63 regulates breast cancer cell malignancy. Mol Cancer.
13:1342014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Nagai Y, Ishimoto T, Baba Y, Mimori K and
Baba H: RPN2 expression predicts response to docetaxel in
oesophageal squamous cell carcinoma. Br J Cancer. 107:1233–1238.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fujiwara T, Takahashi RU, Kosaka N, Nezu
Y, Kawai A, Ozaki T and Ochiya T: RPN2 gene confers osteosarcoma
cell malignant phenotypes and determines clinical prognosis. Mol
Ther Nucleic Acids. 3:e1892014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan TM, Liang RY, Chueh PJ and Chuang SM:
Role of ribophorin II in the response to anticancer drugs in
gastric cancer cell lines. Oncol Lett. 9:1861–1868. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Loo LW, Tiirikainen M, Cheng I, Lum-Jones
A, Seifried A, Church JM, Gryfe R, Weisenberger DJ, Lindor NM,
Gallinger S, et al: Integrated analysis of genome-wide copy number
alterations and gene expression in microsatellite stable, CpG
island methylator phenotype-negative colon cancer. Genes
Chromosomes Cancer. 52:450–466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ju KD, Lim JW and Kim H: Peroxisome
proliferator-activated receptor-gamma inhibits the activation of
STAT3 in cerulein-stimulated pancreatic acinar cells. J Cancer
Prev. 22:189–194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim EY, Jung JY, Kim A, Chang YS and Kim
SK: ABT-737 synergizes with cisplatin bypassing aberration of
apoptotic pathway in non-small cell lung cancer. Neoplasia.
19:354–363. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang SN, Ruan HZ, Chen MY, Zhou G and
Qian ZM: Aspirin increases ferroportin 1 expression by inhibiting
hepcidin via the JAK/STAT3 pathway in interleukin 6-treated PC-12
cells. Neurosci Lett. 662:1–5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun Y, Zhou P, Chen S, Hu C, Bai Q, Wu H,
Chen Y, Zhou P, Zeng X, Liu Z, et al: The JAK/STAT3 signaling
pathway mediates inhibition of host cell apoptosis by Chlamydia
psittaci infection. Pathog Dis. Aug 3–2017.(Epub ahead of
print). doi: 10.1093/femsle/ftx088. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Xu J and Xing G: Lycorine inhibits
the growth and metastasis of breast cancer through the blockage of
STAT3 signaling pathway. Acta Biochim Biophys Sin (Shanghai).
49:771–779. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berthenet K, Bokhari A, Lagrange A,
Marcion G, Boudesco C, Causse S, De Thonel A, Svrcek M, Goloudina
AR, Dumont S, et al: HSP110 promotes colorectal cancer growth
through STAT3 activation. Oncogene. 36:2328–2336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan Y, Su C, Hang M, Huang H, Zhao Y, Shao
X and Bu X: Recombinant Newcastle disease virus rL-RVG enhances the
apoptosis and inhibits the migration of A549 lung adenocarcinoma
cells via regulating alpha 7 nicotinic acetylcholine receptors in
vitro. Virol J. 14:1902017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo JM, Cao FL, Meng C, Lin LJ, Ma SQ,
Peng SH, Gao HL, Javidiparsijani S, Wang GR, Zhang ML, et al:
Clinicopathological and molecular characteristics of synchronous
gastric adenocarcinoma and gastrointestinal stromal tumors. Sci
Rep. 7:128902017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Naine SJ, Devi CS, Mohanasrinivasan V,
Doss CG and Kumar DT: Binding and molecular dynamic studies of
sesquiterpenes
(2R-acetoxymethyl-1,3,3-trimethyl-4t-(3-methyl-2-buten-1-yl)-1t-cyclohexanol)
derived from marine Streptomyces sp. VITJS8 as potential
anticancer agent. Appl Microbiol Biotechnol. 100:2869–2882. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li T, Ding ZL, Zheng YL and Wang W:
MiR-484 promotes non-small-cell lung cancer (NSCLC) progression
through inhibiting Apaf-1 associated with the suppression of
apoptosis. Biomed Pharmacother. 96:153–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taira J, Sonamoto M and Uehara M: Dual
biological functions of a cytoprotective effect and apoptosis
induction by bioavailable marine carotenoid fucoxanthinol through
modulation of the Nrf2 activation in RAW264.7 macrophage cells. Mar
Drugs. 15:E3052017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Q, Li M, Chen M, Zhou L, Zhao L, Hu
R, Yan R and Dai K: Lovastatin induces platelet apoptosis. Environ
Toxicol Pharmacol. 42:69–75. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hazama Y, Moriya T, Sugihara M, Sano R,
Shiota M, Nakamura T and Shimoya K: The analysis of cell
cycle-related proteins in ovarian clear cell carcinoma versus
high-grade serous carcinoma. Int J Gynecol Pathol. Oct
10–2017.(Epub ahead of print). doi: 10.1097/PGP.0000000000000461.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Li Y, Lin M, Jin J and Huang Z:
Rhodium (II) complex with 2-benzoylpyridine, a novel potential
chemotherapeutic drug, induces cell cycle arrest and apoptosis in
HepG2 cells. Biometals. 30:903–915. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He S, Liao B, Deng Y, Su C, Tuo J, Liu J,
Yao S and Xu L: MiR-216b inhibits cell proliferation by targeting
FOXM1 in cervical cancer cells and is associated with better
prognosis. BMC Cancer. 17:6732017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu L, Zhang C, Li X, Sun W, Qin S, Qin L
and Wang X: miR-223 promotes colon cancer by directly targeting
p120 catenin. Oncotarget. 8:63764–63779. 2017.PubMed/NCBI
|
|
33
|
Liu H, Zhen Q and Fan Y: LncRNA GHET1
promotes esophageal squamous cell carcinoma cells proliferation and
invasion via induction of EMT. Int J Biol Markers. 32:e403–e408.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pisamai S, Rungsipipat A, Kunnasut N and
Suriyaphol G: Immunohistochemical expression profiles of cell
adhesion molecules, matrix metalloproteinases and their tissue
inhibitors in central and peripheral neoplastic foci of feline
mammary carcinoma. J Comp Pathol. 157:150–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ohba S, Lanigan TM and Roessler BJ: Leptin
receptor JAK2/STAT3 signaling modulates expression of Frizzled
receptors in articular chondrocytes. Osteoarthritis Cartilage.
18:1620–1629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li W, Zhang H, Nie M, Tian Y, Chen X, Chen
C, Chen H and Liu R: Ursolic acid derivative FZU-03,010 inhibits
STAT3 and induces cell cycle arrest and apoptosis in renal and
breast cancer cells. Acta Biochim Biophys Sin (Shanghai).
49:367–373. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou W, Bi X, Gao G and Sun L: miRNA-133b
and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling
pathway in human renal carcinoma cells. Biomed Pharmacother.
84:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu L and Ding X: Molecular design of
Stat3-derived peptide selectivity between BET proteins Brd2 and
Brd4 in ovarian cancer. J Mol Recognit. Oct 6–2017.(Epub ahead of
print). doi: 10.1002/jmr.2679.
|
|
39
|
Liu X, Wei W, Li X, Shen P, Ju D, Wang Z,
Zhang R, Yang F, Chen C, Cao K, et al: BMI1 and MEL18 promote
colitis-associated cancer in mice via REG3B and STAT3.
Gastroenterology. 153:1607–1620. 2017. View Article : Google Scholar : PubMed/NCBI
|
